Mitchell Sinkler & Starr’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mitchell Sinkler & Starr’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+847	New	+$186K	0.09%	152

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mitchell Sinkler & Starr's JAZZ Position: Q2 2026 in Review

Mitchell Sinkler & Starr opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 847 shares worth $204K. The stake represents 0.09% of the portfolio and ranks #152 among its holdings.

130 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Mitchell Sinkler & Starr held 847 shares of Jazz Pharmaceuticals worth $204K as of Q2 2026.
Jazz Pharmaceuticals was a new Mitchell Sinkler & Starr position in Q2 2026.
Jazz Pharmaceuticals made up 0.09% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #152 holding.
130 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.